John Crowley

John F. Crowley is a highly accomplished leader in the fields of human health and technology and the Chairman & CEO of Amicus Therapeutics.

With over two decades of experience, John is driven by a personal mission to advance biotechnologies for individuals in need, inspired by his children's battle with a severe neuromuscular disorder.

He approaches decision-making with a patient-centered focus and an entrepreneurial mindset, aiming to improve the lives of those facing devastating illnesses globally.

In addition to his role at Amicus Therapeutics, John is involved in various prestigious organizations such as the Aspen Institute and serves on the board of Intellia Therapeutics, Inc.

His commitment to philanthropy is evident through his former position as the National Chairman of the Make-A-Wish Foundation of America and his service in the United States Navy Reserve.

John's impressive educational background includes a Master of Business Administration from Harvard Business School, a Doctor of Law from the University of Notre Dame Law School, a BSFS in International Economics from Georgetown University, and training at the United States Naval Academy.

Throughout his career, John has held key positions in renowned organizations such as Genzyme Therapeutics, Novazyme Pharmaceuticals, Bristol-Myers Squibb, and Marakon Associates.

He excels at leading his team with integrity, empathy, and dedication, striving to make a meaningful impact on the lives of individuals battling rare and devastating diseases.